Article Information
vol. 49 no. 5
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 6, 2016
- Accepted February 9, 2017
- Published online May 19, 2017.
Copyright & Usage
Copyright ©ERS 2017
Author Information
- Harold R. Collard1⇑,
- Luca Richeldi2,3,
- Dong Soon Kim4,
- Hiroyuki Taniguchi5,
- Inga Tschoepe6,
- Maurizio Luisetti†7,
- Jesse Roman8,
- Gregory Tino9,
- Rozsa Schlenker-Herceg10,
- Christoph Hallmann11 and
- Roland M. du Bois12
- 1Division of Pulmonary and Critical Care Medicine, Dept of Medicine, University of California San Francisco, San Francisco, CA, USA
- 2National Institute for Health Research Southampton Respiratory Biomedical Research Unit and Clinical and Experimental Sciences, University of Southampton, Southampton, UK
- 3Division of Respiratory Medicine, Università Cattolica del Sacro Cuore, Fondazione Policlinico “A. Gemelli”, Rome, Italy
- 4Asan Medical Center, University of Ulsan, Seoul, South Korea
- 5Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, Japan
- 6PRA Health Sciences, Paris, France
- 7University of Pavia, Pavia, Italy
- 8University of Louisville School of Medicine and Robley Rex VA Medical Center, Louisville, KY, USA
- 9Penn Presbyterian Medical Center, Dept of Medicine, Philadelphia, PA, USA
- 10Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
- 11Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany
- 12Imperial College, London, UK
- Harold R. Collard, Division of Pulmonary and Critical Care Medicine, Dept of Medicine, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA, 94131, USA. E-mail: Hal.Collard{at}ucsf.edu
Funding
Boehringer Ingelheim
Article usage
Altmetrics
Vol 49 Issue 5
Table of Contents
Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis
